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Abstract: The structure and function of an enzyme can be altered by nanoparticles (NPs). 
The interaction between enzyme and NPs is governed by the key properties of NPs, such as 
structure, size, surface chemistry, charge and surface shape. Recent representative studies 
on the NP-enzyme interactions and the regulation of enzyme activity by NPs with different 
size, composition and surface modification are reviewed. 
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1. Introduction 
 
The regulation of the protein activity plays an important role in modulating cellular processes such 
as signal transduction, DNA replication, and metabolism [1,2]. Protein dysfunction is related to human 
diseases and disorders [3-7], and our ability to regulate enzyme functions and protein-protein 
interactions provides a promising strategy for therapy. Nanoparticles (NPs) have some advantages over 
small organic molecules. First, NPs have large specific surface areas for adequate protein binding and 
biological interactions [1,8]. Second, NP can enter cells easily [10], in contrast to some small 
molecules and biological molecules. Third, there has been considerable progress in the synthesis of 
NPs with well controlled dimensions, geometry, and surface properties [9], to complement the 
structural complexity of proteins [11,12]. Recent developments in nano materials offer a new pathway 
for controlling protein behavior through surface interactions. 
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In the past few years, NPs with different dimensions, composition and surface modification were 
investigated to understand their interactions with proteins. The hydrophobic interaction [13-15], π-π 
stacking [16-18] and electrostatic interaction [19-21] have been attributed to be major mechanisms of 
NP-protein interactions. These mechanisms often coexist.   
This review, by summarizing recent research on nanoparticle/protein interactions, intends to 
emphasize the importance of such interactions in biological systems that may cause nanotoxicity issues, 
and the potential of such molecular recognition events in biomedical applications such as the diagnosis 
and treatment of human diseases.   
 
2. Effects of Mixed Monolayer Protected Nano Clusters (MMPCs) 
 
Mixed monolayer protected gold clusters (MMPCs) provide an effective scaffold for biomolecular 
binding. MMPCs were synthesized using the Brust reduction and Murray place-displacement reaction 
[24] to fabricate additional functionalized thiols ended with carboxylate groups and amino groups, 
respectively [MMPCs 1, 2, and 3 in Figure 1(c) featuring a 2-nm gold core, with an overall diameter of 
6 nm] [25]. These particles exhibited different effects on chymotrypsin (ChT) activity. The cationic 
MMPC 3 had no inhibition, while the anionic MMPC 1 and 2 were effective inhibitors of ChT because 
of the electrostatic complementarity between the carboxylate end groups and the hole of cationic 
residues located around the periphery of the active site, as shown in Figure 1(b). Complete inhibition 
was observed at a 1:5 nanoparticle to ChT ratio. 
Figure 1. (a) Space-filling model of ChT. Surface binding of the proteins by anionic 
MMPCs focuses on the ring of cationic residues situated around the active site, 
functionally significant residues are noted. (b) Relative sizes of ChT and MMPC 1. (c) 
Anionic MMPCs 1 and 2 and cationic control 3 (reproduced with permission from [25] 
© 
2004, National Academy of Sciences, U.S.A). 
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The activity assay indicated that the inhibition of ChT by MMPCs was controlled by a two-stage 
mechanism featuring a fast reversible inhibition, followed by a slower irreversible process. Circular 
dichroism measurements of the complex demonstrated an almost complete denaturation of the enzyme 
over time. Dynamic light scattering studies confirmed that inhibition proceeded without substantial 
MMPC aggregation. The electrostatic nature of the engineered interactions provides a level of 
selectivity: little or no inhibition of functions of elastase, β-galactosidase, or cellular retinoic acid 
binding protein by MMPC was observed. 
Figure 2. (a) Space-filling model of ChT. Active site (yellow) is surrounded by a ring of 
cationic residues (blue). (b) Amphiphilic MMPCs with anionic functional groups (red) in 
their terminals can interact with ChT via electrostatic complementarity. (c) Four 
derivatives of trimethylamine-functionalized surfactant used for surface modification of 
MMPC anionic monolayer. (d) Monolayer composition of AuCOOH (reproduced with 
permission from [26] 
© 2003, American Chemical Society). 
 
The “irreversible” inhibition of ChT can be reversed through modification of the anionic MMPC 
surface by the addition of cationic surfactants [26]. Four derivatives of trimethylamine-functionalized 
surfactants were used to modifiy the gold nanoparticles (GNPs) with carboxylate endgroups (4, 5, 6 
and 7 in Figure 2c, featuring a 2-nm gold core, with an overall diameter of 6 nm). Up to 50% of 
original ChT activity was rescued upon long-chain surfactant addition. Dynamic light scattering 
studies demonstrated that ChT released from the nanoparticle surface and the conformation 
characterization of the rescued ChT by fluorescence and fluorescence anisotropy indicated that ChT 
regained a high degree of native structure upon surfactant addition. The proposed mechanism of the 
ChT release: the MMPC 5  and MMPC 6  can elicit ChT release by interaction and/or partial 
displacement of the anionic monolayer. The MMPC 4, a bilayer-type structure, can release ChT when 
it envelops the MMPC surface, as shown schematically in Figure 3. The noncovalent nature of the Int. J. Mol. Sci. 2009, 10                 
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irreversible inhibition of ChT shows that the attenuation of the interactions the MMPC and protein 
could provide a means of rescuing enzyme activity. 
 
Figure 3. Proposed mechanism of ChT rescue. The surfactants with thiol 5 and alcohol 6 at 
their terminals have the ability to elict ChT release by interaction and/or partial 
displacement of the anionic monolayer. C11 alkane 4 forms a bilayer-like structure, causing 
release of the ChT (red = anionic; blue = cationic) (reproduced with permission from [26] 
© 
2003, American Chemical Society). 
 
3. Influence of the Size of NP on the Activity of Adsorbed Enzymes 
 
The size of NPs is one of the key parameters that influence the interaction between protein and NPs. 
Silica NPs with different diameters (4, 20 and 100 nm) were used to investigate the size influence on 
the structure and enzymatic activity of adsorbed lysozyme, whose dimensions are comparable in size 
to the 4 nm NPs [27].
 Both adsorption patterns and protein structure and function are strongly 
dependent on the size of the NPs. The formation of molecular complexes is observed for adsorption 
onto 4-nm silica. The CD results proved that the loss in α-helix content is strongly dependent on the 
size of the NPs. The great loss of α helicity was observed for the lysozyme adsorbed onto larger NPs. 
The activity of lysozyme adsorbed onto silica NPs is lower than that of the free protein, and the 
fraction of activity lost correlates well with the decrease in α-helix content. These results indicate that 
the size of the NP, perhaps because of the contributions of surface curvature, influences adsorbed 
protein structure and function (Figure 4).  
The same phenomenon was also observed when ribnuclease A [28] and human carbonic anhydrase 
[29] were absorbed onto silica NPs surfaces with different sizes.
 Urea denaturation analyses showed 
that the thermodynamic stability of ribnuclease A was decreased upon adsorption on to the NPs, with 
greater decrease on larger NPs. Therefore, the larger NPs tend to cause unfolding of adsorbed  
proteins [28]. 
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Figure 4. Schematic of lysozyme adsorption on silica particles with different sizes. 
Stronger protein particle interactions exist in the case of larger nanoparticles, resulting in 
more protein unfolding and less enzymatic activity (reproduced with permission from [27] 
© 2004, American Chemical Society). 
 
 
 
4. Conformational Changes as a Result of NP/Protein Binding 
 
Applications from diagnostics to drug delivery require that enzymes retain their native structures 
and activities. Conjugates of acid-treated SWNTs with three functionally unrelated enzymes 
horseradish peroxidase, subtilisin Carlsberg, and chicken egg white lysozymes were found to be 
soluble in aqueous solutions [30]. Enzyme kinetics revealed that these enzymes retained a high 
fraction of their native structures and activities. The SWNT-enzyme conjugates were also more stable 
in guanidine hydrochloride (GdnHCl) and at elevated temperatures relative to their solution 
counterparts. These studies demonstrate the enhanced stability of SWNT-enzyme preparations relative 
to free enzymes in solution. Such water-soluble enzyme-nanotube conjugates may be useful in a wide 
range of applications. 
Two enzymes, α-chymotrypsin and soybean peroxidase, were adsorbed onto the single-walled 
carbon nanotubes. α-chymotrypsin retained only 1% of its native activity while soybean peroxidase 
retained 30% of its native activity. The FT-IR spectroscopy revealed that substantial secondary 
structural perturbation is occurred after ChT binding to the SWNTs. This phenomenon was caused by 
the hydrophobic interaction between the SWNTs and the proteins. Soybean peroxidase had a 
hydrophobic pocket that bound to SWNTs leaving the active site exposed to the solvent to bind 
substrate. Denaturation of ChT was responsible for low activity (Figure 5) [31]. If the nanomaterial 
surface is modified with hydrophilic polymers such as oligomeric PEG moieties, the interactions of 
NPs and proteins may be alleviated [32]. 
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Figure 5. (a) PDB structure of SBP showing the hydrophobic pocket. Hydrophobic and 
hydrophilic residues are shown in blue and yellow, respectively, while the asparagines 
residues that are glycosylated are shown in green and the heme is shown in red. (b) A 
schematic hypothesizing the adsorption of SBP onto SWNTs via the hydrophobic pocket 
on SBP (reproduced with permission [31] 
© 2004, American Chemical Society). 
 
 
5. Regulation of Enzyme Function by Surface-Modified NPs 
 
Compared with traditional materials, NPs have a larger surface area that can be modified with 
organic molecules through covalent or non-covalent modifications to form functionalized NPs. The 
suitably functionalized NPs possess the abilities that prinstine NPs do not have, such as preventing 
non-specific bindings and recognizing specific biomacromolecules. In this way, enzyme activities can 
be specifically regulated when bound to surface modified NPs. 
Three silicon nanowires (SiNW) [33], unmodified silicon nanowires (SiNW-SiO2), SiNWs 
functionalized with carboxylic groups (SiNW-COOH) and highly reactive hydrogen modified SiNW 
(SiNW-H) were synthesized to investigate their affect on restriction endonucleases and Taq DNA 
polymerase. The PCR results showed that the inhibition of enzyme activity was determined by the 
functional groups on SiNWs in the order SiNW-H > SiNW-COOH > SiNW-SiO2.  
Specific NP/protein binding provides a better opportunity for regulating enzyme functions. 
Carbonic anhydrase inhibitor 8 linked to gold NPs (GNP-8, with an average particle size of 3.3 nm, 
which corresponds to 720-724 Au atoms) showed excellent CA IX inhibition of the tumer-associated 
isoform and selectivity over hCA I and II (Table 1, Figure 6) [34] due to the fact that their binding 
pocket contains different residues. Table 1 listed the inhibition of CA I, II and IX
a by acetazolamide Int. J. Mol. Sci. 2009, 10                 
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(AZA), sulfonamides 8,  9,  GNP-8 and GNP-9. It has been also shown that molecules such as 
antibodies, which can recognize protein specifically, can be linked to NPs to recognize proteins 
through specific antibody-antigen interactions [35,36]. 
 
Table 1. CA inhibition data against isoforms CA I, II and IX.
 a 
 
 
 
 
 
 
 
 
 
a    Reproduced with permission from [34] 
© 2003, American Chemical Society. 
b Inhibition constants (Ki) are obtained by nonlinear least-squares methods after 
being incubated with compound 15min.Data in parentheses show the inhibition 
constants when enzyme and inhibitor were incubated for 2 h. 
 
Figure 6. Structure of the acetazolamide AZA, the new sulfonamides 8, 9, GNP-8 and GNP-9. 
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We have synthesized a novel surface-modified multi-wall carbon nanotube combinatorial library 
containing 80 members by using in silico design and combinatorial synthesis [37]. By screening the 
library we discovered MWNTs with reduced protein binding, reduced cytotoxicity, and immune 
response. The ChT enzymatic activity and fluorescent quenching were measured by incubating ChT 
with functionalized multiwalled carbon nanotube (f-MWNTs, were synthesized by chemical vapor 
deposition. The purity was 95% and the catalyst residue was less than 0.2%. They are 40 nm in 
diameter and the length is 500-2,000 nm) (Figure 7A). By screening the library [38], we discovered 
four f-MWNTs that can bind to the catalytic site of ChT site-specifically and inhibit its enzymatic 
activity competitively (Figure 7B). Our results demonstrated that specific recognition of ChT and 
regulation of its functions by surface-modified MWNT. 
  Ki
b (nM) 
Compound  hCA I  hCA II  hCA IX 
AZA  250 ± 12  12 ± 1  25 ± 1 
8  214 ± 9  230 ± 10  41 ± 2 
GNP-8  581 ± 18 (128)  451 ± 21 (116)  32 ± 2 (2.4) 
9  >50,000 >50,000  >50,000 
GNP-9  28,550 30,400  31,050 
Au  32,000 31,600  29,560 Int. J. Mol. Sci. 2009, 10                 
   
 
4205
Figure 7. (a) The quenching of ChT’s fluorescence (left) and inhibition of its enzymatic 
activity (right) by f-MWNTs. (b) Models showing different ways f-MWNTs bind to ChT 
(reproduced with permission from [38] 
© 2004, American Chemical Society). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. Fine Tuning of NP/Protein Interactions 
 
CdSe particles modified with thioalkylated oligo(ethylene glycol) and chain-end carboxylate were 
synthesized [39]. The study of the interactions between CdSe NPs and chymotrypsin revealed three 
levels of inhibition: (1) protein inhibition and denaturation with NP-10, (2) no protein binding with 
NP-11, and (3) inhibition and retention of the protein structure with NP-12. The NP-10  with 
alkanethiol-carboxylate functionalized can bind, inhibit, and denaturate of ChT because of the 
hydrophobic interactions. The NP-11, lacking of the carboxylate recognition element, was inert in 
protein binding. The NP-12, modified with tetraethylene glycol spacer between the alkyl chain and 
recognition element, can inhibit ChT reversibly because of the electrostatic interaction between the 
particle and protein, but prevents hydrophobic interactions caused by the interior alkyl chain   
(Figure 8). 
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Figure 8. Ligands used for CdSe nanoparticles, and schematic depiction of protein-
nanoparticle interactions (reproduced with permission from [39] 
© 2004, American 
Chemical Society).   
 
 
In order to explore how the linkages between recognition elements and NP core affect the 
NP/enzyme interacion. A series of L-amino acid functionalized GNPs with oligo (ethylene glycol) 
tethers of varying length were studied. It has been shown that amino acid side chains can maintain the 
ChT structure while the alkyl chains denature the protein as a result of nonspecific hydrophobic 
interactions [40]. 
Structure diversity can also be generated by introducing amino acids in the surface modification. 
The hydrophobic interaction and the complementary electrostatic interactions between Au 
nanoparticles with L-amino acids as endgroups and ChT also plays an important role in regulating ChT 
activity [41]. 
Protein-protein recognition is a key aspect of the complex cellular functions, such as apoptosis and 
angiogenesis. Control over interprotein recognition holds the potential in therapeutic applications. 
Thiolates with biocompatible PEG linker and trimethyl-amine end group were used to functionalize 
Au nanoparticles. And it can inhibit interactions between cytochrome c and cytochrome c perxidase in 
the low nM concentration range [42]. 
 
7. Conclusions 
 
Enzyme dysfunction is related to human diseases. It is desirable to be able to regulate enzyme 
conformation and function. Nano sensors incorporating enzymes also require that protein conformation 
is not altered, further emphasizing the importance of protein regulation. NPs can be selected to Int. J. Mol. Sci. 2009, 10                 
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specifically bind enzymes and control their functions after surface modifications. Such NP/protein 
interactions can be fine-tuned to maintain protein structure or alter it on purpose. 
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